Meanwhile, tirzepatide another rapidly growing GLP-1 therapy category continued to show resilience despite rising competitive intensity
Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise
How Health Canada describes the generic product The agency described the Dr
Understanding the root causes of your health challenges is central to our philosophy
Peptides per protocol: Sermorelin = 1
When your gut lining is coming together-usually the 2 to 3 week mark, add probiotics